The U.S. Fabry Disease Treatment Market is projected to grow from USD 1.09 Billion in 2025 to USD 2.38 Billion by 2035, while Europe is expected to expand from USD 0.76 Billion to USD 1.67 Billion, driven by increasing orphan drug adoption, enzyme replacement therapy utilization, and rare disease diagnosis initiatives.
The U.S. Fabry Disease Treatment Market is projected to grow from USD 1.09 Billion in 2025 to USD 2.38 Billion by 2035, while Europe is expected to expand from USD 0.76 Billion to USD 1.67 Billion, driven by increasing orphan drug adoption, enzyme replacement therapy utilization, and rare disease diagnosis initiatives.